137 related articles for article (PubMed ID: 6994007)
21. New "rescue" with massive doses of citrovorum factor for potentially lethal methotrexate toxicity.
Djerassi I; Kim JS; Nayak N; Ohanissian H; Adler S; Hsieh S
Cancer Treat Rep; 1977 Jul; 61(4):749-50. PubMed ID: 301784
[No Abstract] [Full Text] [Related]
22. Methotrexate with citrovorum factor rescue for nonmetastatic gestational trophoblastic neoplasms.
Goldstein DP; Goldstein PR; Bottomley P; Osathanondh R; Marean AR
Obstet Gynecol; 1976 Sep; 48(3):321-3. PubMed ID: 181702
[TBL] [Abstract][Full Text] [Related]
23. Phase II clinical trial with high-dose methotrexate therapy and citrovorum factor rescue.
Isacoff WH; Eilber F; Tabbarah H; Klein P; Dollinger M; Lemkin S; Sheehy P; Cone L; Rosenbloom B; Sieger L; Block JB
Cancer Treat Rep; 1978 Sep; 62(9):1295-304. PubMed ID: 356984
[TBL] [Abstract][Full Text] [Related]
24. Progress report on high-dose methotrexate (NSC-740) with citrovorum rescue in the treatment of metastatic bone tumors.
Jaffe N
Cancer Chemother Rep; 1974; 58(2):275-80. PubMed ID: 4598245
[No Abstract] [Full Text] [Related]
25. Methotrexate and citrovorum factor after histoincompatible allogeneic bone marrow transplants in dogs.
Gratwohl AA; Bull MI; Graw RG; Norton L; Knutsen T
Acta Haematol; 1978; 60(4):233-42. PubMed ID: 30247
[TBL] [Abstract][Full Text] [Related]
26. Incidence of drug-related deaths secondary to high-dose methotrexate and citrovorum factor administration.
Von Hoff DD; Penta JS; Helman LJ; Slavik M
Cancer Treat Rep; 1977 Jul; 61(4):745-8. PubMed ID: 301783
[TBL] [Abstract][Full Text] [Related]
27. [Management of the administration of leucovorin calcium in high-dose methotrexate therapy].
Kickinger W; Ritschl P; Kotz R
Arzneimittelforschung; 1989 Jun; 39(6):728-31. PubMed ID: 2789050
[TBL] [Abstract][Full Text] [Related]
28. [High-dose methotrexate with citrovorum factor rescue in the treatment of malignant tumors (author's transl)].
Wang QL; Sun Y; Zhou JC; Song SZ; Lu L; Ye ZS
Zhonghua Zhong Liu Za Zhi; 1979; 1(2):144-9. PubMed ID: 317948
[No Abstract] [Full Text] [Related]
29. Methotrexate-induced leukoencephalopathy is treatable with high-dose folinic acid: a case report and analysis of the literature.
Cohen IJ; Stark B; Kaplinsky C; Weitz R; Matz S; Lerman P; Rakowsky E; Vogel R; Zaizov R
Pediatr Hematol Oncol; 1990; 7(1):79-87. PubMed ID: 2204409
[TBL] [Abstract][Full Text] [Related]
30. High-dose methotrexate-citrovorum factor rescue in the management of brain tumors.
Djerassi I; Kim JS; Shulman K
Cancer Treat Rep; 1977 Jul; 61(4):691-4. PubMed ID: 301782
[No Abstract] [Full Text] [Related]
31. Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.
Abelson HT; Fosburg MT; Beardsley GP; Goorin AM; Gorka C; Link M; Link D
J Clin Oncol; 1983 Mar; 1(3):208-16. PubMed ID: 6607976
[TBL] [Abstract][Full Text] [Related]
32. Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancer.
Barlow JJ; Piver MS
Gynecol Oncol; 1979 Apr; 7(2):233-8. PubMed ID: 312234
[No Abstract] [Full Text] [Related]
33. Thymidine rescue of high-dose methotrexate in humans.
Howell SB; Ensminger WD; Krishan A; Frei E
Cancer Res; 1978 Feb; 38(2):325-30. PubMed ID: 637906
[TBL] [Abstract][Full Text] [Related]
34. [Studies on high-dose methotrexate with citrovorum factor rescue therapy in children: analysis of bone marrow cell kinetics by flow cytometry].
Tsurusawa M; Sasaki K; Matsuoka H; Katano N; Fujimoto T
Gan To Kagaku Ryoho; 1985 Sep; 12(9):1827-32. PubMed ID: 3876075
[TBL] [Abstract][Full Text] [Related]
35. Essential laboratory determinations for monitoring high-dose methotrexate treatment with citrovorum factor rescue.
Jürgens H; Ebell W; Bachmann R; Kupke I; Richter O; Andräs A; Göbel U
Pediatr Pharmacol (New York); 1983; 3(3-4):157-65. PubMed ID: 6610851
[TBL] [Abstract][Full Text] [Related]
36. Rescue after intermediate and high-dose methotrexate: background, rationale, and current practice.
Borsi JD; Sagen E; Romslo I; Moe PJ
Pediatr Hematol Oncol; 1990; 7(4):347-63. PubMed ID: 2268535
[TBL] [Abstract][Full Text] [Related]
37. High-dose methotrexate with citrovorum factor rescue for patients with refractory lymphoproliferative disorders.
Case DC
J Maine Med Assoc; 1980 Dec; 71(12):355-8. PubMed ID: 6970790
[No Abstract] [Full Text] [Related]
38. [Moderate dose methotrexate with citrovorum factor rescue therapy in the treatment of head and neck cancer].
Inuyama Y; Hiroto I; Taketa C; Horiuchi M; Mashino S; Fujii M; Matsuura S; Satake B; Takeoda S; Nishijima W; Okuda M; Sakaguchi K; Tanigaito Y; Imakirei M; Konno T; Hirokawa T; Takada K; Ono I; Saitoh H; Takemiya S; Shimada F; Omura K; Miyake H; Fujii K; Kawabe Y; Kondoh T; Komiyama S; Yanagida T; Matsumura Y; Hirano M; Araki S
Gan To Kagaku Ryoho; 1982 Dec; 9(12):2193-200. PubMed ID: 6764099
[TBL] [Abstract][Full Text] [Related]
39. Comparison of thymidine and folinic acid protection from methotrexate toxicity in human lymphoid cell lines.
Browman GP
Cancer Treat Rep; 1982 Dec; 66(12):2051-9. PubMed ID: 6982753
[TBL] [Abstract][Full Text] [Related]
40. Assay for citrovorum factor (NSC-3590) in the presence of methotrexate (NSC-740).
Mehta BM; Hutchison DJ
Cancer Chemother Rep; 1975; 59(5):935-7. PubMed ID: 1081908
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]